Form 4: Director Michael Ellenbogen Trades Evolv Technologies Stock

Director Michael Ellenbogen reported transactions involving Evolv Technologies Holdings, Inc. (EVLV) Class A Common Stock, including acquisitions and dispositions.

Summary

• Director Michael Ellenbogen of Evolv Technologies Holdings, Inc. reported a series of transactions on June 15, 2026.
• These transactions included the acquisition of 80,745 shares of Class A Common Stock at a price of $0.24 per share.
• Additionally, 80,745 shares were disposed of at a weighted average price of $6.21 per share.
• Following these transactions, the reporting person beneficially owns 2,083,961 shares directly.
• A total of 151,135 shares are held indirectly by the Family Horizon Trust.
• The transactions were executed under a Rule 10b5-1 trading plan established on June 12, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports routine insider transactions under a pre-established plan rather than new strategic information or significant financial performance updates.

Positives

• Acquisition of 80,745 shares at a favorable price of $0.24 per share.
• The transactions were conducted under a pre-established Rule 10b5-1 trading plan, indicating a structured and pre-determined approach to trading.
• The reporting person retains a significant number of shares (2,083,961 directly and 151,135 indirectly), suggesting continued confidence in the company.

Negatives

• Disposition of 80,745 shares at a significantly higher price ($6.21 weighted average) than the acquisition price ($0.24), indicating a sale at a profit.
• The weighted average sale price of $6.21 suggests that the market value at the time of sale was considerably higher than the acquisition price.

Risks

• The Rule 10b5-1 plan implies that the director is selling shares, which could be interpreted by the market as a lack of confidence, although the plan is designed to mitigate insider trading concerns.
• The significant difference between the acquisition price and the sale price might indicate a substantial increase in the stock's value, but also a realization of gains by the insider.

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports past transactions.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The use of a Rule 10b5-1 plan is a common strategy for executives to diversify holdings or manage personal finances while adhering to insider trading regulations. The specific details of the transactions, including the acquisition and sale prices, provide insight into the insider's perspective on the stock's valuation at different points in time.

Stakeholder Impact

• Shareholders: The sale of shares by a director, even under a 10b5-1 plan, can sometimes be perceived negatively by the market, although the plan is designed to mitigate this. The continued beneficial ownership by the director suggests ongoing commitment.
• Management: The filing is a routine disclosure and does not directly impact other management personnel, but it highlights adherence to corporate governance and trading policies.
• Creditors/Suppliers: No direct impact is indicated by this filing.

Next Steps

• Monitor future Form 4 filings for any further transactions by Michael Ellenbogen or other insiders.
• Observe the market's reaction to these reported transactions, if any.

Key Dates

Keywords

Form 4, SEC Filing, Insider Trading, Beneficial Ownership, Evolv Technologies, EVLV, Stock Transaction, Rule 10b5-1, Director Transactions, Class A Common Stock